Literature DB >> 21165329

Response of i(kr) and HERG currents to the antipsychotics tiapride and sulpiride.

Su-Hyun Jo1, So-Young Lee.   

Abstract

The human ether-a-go-go-related gene (hERG) channel is important for repolarization in human myocardium and is a common target for drugs that prolong the QT interval. We studied the effects of two antipsychotics, tiapride and sulpiride, on hERG channels expressed in Xenopus oocytes and also on delayed rectifier K(+) currents in guinea pig cardiomyocytes. Neither the amplitude of the hERG outward currents measured at the end of the voltage pulse, nor the amplitude of hERG tail currents, showed any concentration-dependent changes with either tiapride or sulpiride (3~300 µM). However, our findings did show that tiapride increased the potential for half-maximal activation (V(1/2)) of HERG at 10~300 µM, whereas sulpiride increased the maximum conductance (G(max)) at 3, 10 and 100 µM. In guinea pig ventricular myocytes, bath applications of 100 and 500 µM tiapride at 36℃ blocked rapidly activating delayed rectifier K(+) current (I(Kr)) by 40.3% and 70.0%, respectively. Also, sulpiride at 100 and 500 µM blocked I(Kr) by 38.9% and 76.5%, respectively. However, neither tiapride nor sulpiride significantly affected the slowly activating delayed rectifier K(+) current (I(Ks)) at the same concentrations. Our findings suggest that the concentrations of the antipsychotics required to evoke a 50% inhibition of I(Kr) are well above the reported therapeutic plasma concentrations of free and total compound.

Entities:  

Keywords:  Rapidly-activating delayed rectifier K+ channel; Slowly-activating delayed rectifier K+ channel; Sulpiride; Tiapride; hERG channel

Year:  2010        PMID: 21165329      PMCID: PMC2997416          DOI: 10.4196/kjpp.2010.14.5.305

Source DB:  PubMed          Journal:  Korean J Physiol Pharmacol        ISSN: 1226-4512            Impact factor:   2.016


  32 in total

1.  The importance of pharmacokinetic data on sulpiride: results of a bioequivalence study of two sulpiride 200 mg preparations following oral administration.

Authors:  G Lenhard; U Kieferndorf; G Berner; U Vögtle-Junkert; H H Wagener
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1991-06

2.  Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents.

Authors:  M C Sanguinetti; N K Jurkiewicz
Journal:  J Gen Physiol       Date:  1990-07       Impact factor: 4.086

3.  Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature.

Authors:  Z Zhou; Q Gong; B Ye; Z Fan; J C Makielski; G A Robertson; C T January
Journal:  Biophys J       Date:  1998-01       Impact factor: 4.033

Review 4.  Antipsychotic drugs and QT prolongation.

Authors:  Claudia Stöllberger; Johannes O Huber; Josef Finsterer
Journal:  Int Clin Psychopharmacol       Date:  2005-09       Impact factor: 1.659

5.  Sulpiride induced torsade de pointes.

Authors:  Bien-Hsien Huang; Chih-Ping Hsia; Chung-Yin Chen
Journal:  Int J Cardiol       Date:  2007-04-03       Impact factor: 4.164

6.  Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients.

Authors:  Lesley H Curtis; Truls Østbye; Veronica Sendersky; Steve Hutchison; Nancy M Allen LaPointe; Sana M Al-Khatib; Sally Usdin Yasuda; Peter E Dans; Alan Wright; Robert M Califf; Raymond L Woosley; Kevin A Schulman
Journal:  Am J Med       Date:  2003-02-01       Impact factor: 4.965

7.  Comparative evaluation of hERG potassium channel blockade by antipsychotics.

Authors:  J S Silvestre; J R Prous
Journal:  Methods Find Exp Clin Pharmacol       Date:  2007-09

Review 8.  Levosulpiride: a review of its clinical use in psychiatry.

Authors:  A Mucci; G Nolfe; M Maj
Journal:  Pharmacol Res       Date:  1995-02       Impact factor: 7.658

9.  Torsadegenic action of the antipsychotic drug sulpiride assessed using in vivo canine models.

Authors:  Atsushi Sugiyama; Yoshioki Satoh; Hiroyuki Shiina; Satoshi Takeda; Keitaro Hashimoto
Journal:  J Cardiovasc Pharmacol       Date:  2002-08       Impact factor: 3.105

10.  Characterization of inhibition by haloperidol and chlorpromazine of a voltage-activated K+ current in rat phaeochromocytoma cells.

Authors:  K Nakazawa; K Ito; S Koizumi; Y Ohno; K Inoue
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

View more
  1 in total

1.  The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.

Authors:  Emanuel Raschi; Elisabetta Poluzzi; Francesco Salvo; Ariola Koci; Marc Suling; Stefania Antoniazzi; Luisella Perina; Lorna Hazell; Ugo Moretti; Miriam Sturkenboom; Edeltraut Garbe; Antoine Pariente; Fabrizio De Ponti
Journal:  Drug Saf       Date:  2016-01       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.